These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4755753)

  • 1. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE; Borsy J; Balogh T
    Acta Pharm Hung; 1973 Sep; 43(5):200-6. PubMed ID: 4755753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
    Borsy J; Magóné KE; Balogh T; Pik K
    Acta Pharm Hung; 1973 Sep; 43(5):207-17. PubMed ID: 4755754
    [No Abstract]   [Full Text] [Related]  

  • 3. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of serotonin inhibitors and derivatives of phenylethylamine on serotonin-induced psychomotor depression in mice].
    Fischer E; Saavedra JM; Smolovich J
    C R Seances Soc Biol Fil; 1968; 162(8):1623-4. PubMed ID: 4238204
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo antiserotonin activity in the unanesthetized guinea pig.
    McKeon WB
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):373-82. PubMed ID: 6049331
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysenyl, a new antiserotonin agent. Pharmacological and clinical survey.
    Podvalová I; Dlabac A
    Res Clin Stud Headache; 1970; 3():325-34. PubMed ID: 5527212
    [No Abstract]   [Full Text] [Related]  

  • 7. LYSERGIC ACID DIETHYL AMIDE (LSD-25): XXXVII. ANTISEROTONIN ACTION OF LYSERGIC ACID DERIVATIVES IN ALLERGY AND NEUROPSYCHIATRY.
    ABRAMSON HA
    J Asthma Res; 1965 Mar; 2(3):257-62. PubMed ID: 14285481
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of lysergic acid derivatives on 5-hydroxytryptamine excitation of brain stem neurones.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Feb; 38(2):453P-454P. PubMed ID: 5417881
    [No Abstract]   [Full Text] [Related]  

  • 9. The antiserotonin properties of benzcyclane.
    Dávid G; Kenedi I
    Acta Physiol Acad Sci Hung; 1968; 34(1):123-7. PubMed ID: 5705050
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new serotonin antagonist derived from lysergic acid in the therapy of hemicrania].
    Franchi G; Fanciullacci M
    Minerva Med; 1969 Oct; 60(87):4313-21. PubMed ID: 5354511
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of hydrophobicity in the antiserotonin activity of LSD analogs.
    Dunn WJ; Bederka JP
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):275-85. PubMed ID: 4818374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents.
    Mawson C; Whittington H
    Br J Pharmacol; 1970 May; 39(1):223P-224P. PubMed ID: 5420115
    [No Abstract]   [Full Text] [Related]  

  • 14. Conformational study of lysergic acid derivatives in relation to their hallucinogenic and antiserotonin activities.
    Kumbar M
    NIDA Res Monogr; 1978; (22):374-407. PubMed ID: 101885
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lesions of the central nervous system in Carassius auratus caused by serotonin and the protective action of lysergic acid diethylamide].
    BRUSA A; GIANNIOTTI G; SACCHI U
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):438-41. PubMed ID: 13374116
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of serotonin antagonists on blood platelet aggregation].
    Rysánek K; Svehla C; Spánková H; Mlejnková M
    Act Nerv Super (Praha); 1968 Oct; 10(3):325-6. PubMed ID: 5702550
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of LSD on the central nervous system (review)].
    Popova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):457-62. PubMed ID: 4978646
    [No Abstract]   [Full Text] [Related]  

  • 20. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.